Skip navigation

Enhance Contract Negotiation and Facilitate Compliance with the Big Four Federal Programs

October 22-23, 2019
  • Philadelphia, PA

Now in its 11th year, CBI’s Federal Pricing and Reporting conference elevates the conversation and dives deep into the complexity of contracting with the “Big Four” federal programs. With legislation and regulation changes on the horizon, this highly acclaimed meeting is a must-attend for bio/pharma manufacturers seeking timely updates, best practices and future opportunities directly from government officials and industry counterparts on pricing models and processes for complying with complicated rules and regulations. Join the hundreds who have benefited over the years and gain invaluable learnings to stay profitable in this low-margin, highly complex market.


  • Review Federal Supply Schedule (FSS) compliance rules post-Acetris Health case with updated knowledge on transparency expectations
  • Examine the possibilities around outcomes-based contracts and other strategies for better compliance and negotiations with the Big Four Federal Programs
  • Managing Refunds of 340B Overcharges and Mitigating Compliance Risk
  • Hear directly from the VA OIG regarding FSS contract compliance and audit expectations
  • Review leading strategies and best practices for coordination with the Department of Defense with new budgeting changes
  • Discuss the impact of drug shortages and limited distribution with an eye towards opportunities for growth and collaboration

Stay tuned for additional 2019 program information and updates!

Previous Attendee Acclaim:

Love the size of the sessions, it lends to knowledge sharing
and a lot of great insightful questions and answers.

Director, Government Pricing & Compliance, Amneal Pharmaceuticals

Very informative, I’m new to this channel and learned a lot.
Thank you!

Associate Director, Policy & Reimbursement Lead, UCB, Inc.

Especially valuable to have VA personnel present and available for discussion. Lots of expertise by speakers and the audience.

Federal Accounts Director, Arbor Pharmaceuticals

The conference gave me valuable information and
industry contacts that will be useful in our relations
and dealings with the government.

Senior Manager, National Accounts, Sagent Pharmaceuticals

Timely and relevant information sharing from
industry experts that has practical application I can
take back to the office with me.

Senior Government Pricing Analyst, AstraZeneca

As someone who works with VA, DOD and PHS,
this program has consistently given me an update
and preparation for the coming year!

Federal Accounts, Teva Pharmaceuticals

It is beneficial to attend to hear the important factors of
government pricing reporting.

Manager, Government Pricing, Merck

Need to keep having this meeting!

Senior Director, Pricing & Contracting, Santarus Inc.

Having VA, NAC and OIG speakers at this conference is
very helpful and informative. Great choices.

Sr. Analyst, Government Pricing, Daiichi Sankyo